Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Brii Biosciences Provides Update on Strategic Clinical Development Progress 2022-12-27 20:00
Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive WHO Prequalification 2022-12-27 10:00
Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development and Manufacturing Services Agreement for Targeted Radiopharmaceutical Therapies 2022-12-27 10:00
MindRank Announces U.S. FDA Clearance of IND Application for MDR-001, a Novel GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes and Obesity 2022-12-26 23:00
Pulnovo Medical will be attending JPM Healthcare Conference 2023 2022-12-24 20:00
Fosun International Granted Three Awards from Global Banking and Finance Review in the United Kingdom 2022-12-23 10:52
JUNIPER BIOLOGICS WINS M&A AWARD 2022 BY ACQUISITION INTERNATIONAL 2022-12-23 09:35
Antengene Announces NDA Submission for XPOVIO® in Macau, Malaysia and Thailand for Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-cell Lymphoma 2022-12-23 08:30
P3 Research secures investment from Genesis Capital to accelerate expansion 2022-12-22 19:36
New STIC trial data shows longer overall survival for therapy selection based on CELLSEARCH® CTC count in patients with metastatic breast cancer 2022-12-22 16:00
Gemini Rosemont adds Peninsula Life Science Center eight-story office building to portfolio in all cash transaction 2022-12-22 11:27
Everest Medicines' Licensing Partner Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis 2022-12-22 08:00
ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances 2022-12-22 06:04
Medidata awarded International Innovation Award for Medidata Sensor Cloud 2022-12-21 14:44
PeproMene Bio, Inc. Announced Complete Response of The First Patient Treated in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope 2022-12-21 09:00
Ascletis' NASH Drug ASC41(THRβ) Phase II Enrollment is Progressing as Planned 2022-12-21 08:00
Sirnaomics Announces Interim Data from Phase I Clinical Trial of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors 2022-12-21 00:39
Sanisure Announces the Acquisition of a Leading Silicone Extrusion Facility in Twinsburg, Ohio 2022-12-21 00:06
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi 2022-12-20 23:16
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia 2022-12-20 20:00
1 100 101 102 103 104 493